The original headline made it sound like the stroke was directly related to the vaccine. The other strokes, cerebral venous sinus thrombosis, are why the vaccine was paused. CVST is a rare form of stroke. It affects about 5 people in 1 million each year. Johnson & Johnson has delivered 8.6 million doses of its vaccine, of which more than 4 million have been administered. So the 6 cases found could easily be within normal range. I would be much more concerned about not getting vasccinated and getting COVD-19 with all its attendant damages, including stroke. But I already got two shots of the Pfizer and only had a lot of fatigue the next day.
Coast dad faces long recovery after stroke. Data so far shows no link to J&J vaccine.
Brad Malagarie, a 43-year-old father of seven from Ocean Springs, faces a long recovery from the stroke he suffered hours after receiving a COVID-19 vaccine from Johnson & Johnson, while medical experts will be studying his case for any link.
However, suspension of the J&J vaccine for by the Centers for Disease Control and Prevention and U.S. Food and Drug Administration is not related to the type stroke Malagarie suffered, an ischemic stroke. Ischemic stroke, the most common type of stroke, happens when a blood clot blocks an artery leading to the brain, cutting off oxygen and blood flow.
Instead, the federal government “paused” use of the J&J vaccine because of six cases of a rare clotting disorder, cerebral venous sinus thrombosis, combined with low blood platelets. Six women, ages 18-48, developed the symptoms 6 to 13 days after vaccination.
To see blood clots in the brain and low blood platelets simultaneously is extremely rare because platelets help blood clot.
Malagarie’s family is not suggesting that people avoid being vaccinated, but they do want the cause of his stroke investigated. His aunt, Celeste O’Keefe, received Moderna vaccinations, but wants more transparency with the J&J vaccine given its troubled manufacturing history.
No comments:
Post a Comment